Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license ...
President Donald Trump is facing new scrutiny over the use of a replicated signature on several recent pardons. Online ...
10h
Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue - - Reports positive feedback from the FDA ...
The mystery behind the “Julius is Coming” posters that appeared across Portsmouth in recent weeks has finally been unveiled.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback